201 related articles for article (PubMed ID: 24729451)
1. Multiple effects of the special AT-rich binding protein 1 (SATB1) in colon carcinoma.
Frömberg A; Rabe M; Aigner A
Int J Cancer; 2014 Dec; 135(11):2537-46. PubMed ID: 24729451
[TBL] [Abstract][Full Text] [Related]
2. Analysis of cellular and molecular antitumor effects upon inhibition of SATB1 in glioblastoma cells.
Frömberg A; Rabe M; Oppermann H; Gaunitz F; Aigner A
BMC Cancer; 2017 Jan; 17(1):3. PubMed ID: 28049521
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of SATB1 promotes tumor growth and metastasis in liver cancer.
Tu W; Luo M; Wang Z; Yan W; Xia Y; Deng H; He J; Han P; Tian D
Liver Int; 2012 Aug; 32(7):1064-78. PubMed ID: 22583549
[TBL] [Abstract][Full Text] [Related]
4. SATB1 as oncogenic driver and potential therapeutic target in head & neck squamous cell carcinoma (HNSCC).
Panchal O; Wichmann G; Grenman R; Eckhardt L; Kunz-Schughart LA; Franke H; Dietz A; Aigner A
Sci Rep; 2020 May; 10(1):8615. PubMed ID: 32451408
[TBL] [Abstract][Full Text] [Related]
5. The Special AT-rich Sequence Binding Protein 1 (SATB1) and its role in solid tumors.
Frömberg A; Engeland K; Aigner A
Cancer Lett; 2018 Mar; 417():96-111. PubMed ID: 29306014
[TBL] [Abstract][Full Text] [Related]
6. Expression of SATB1 promotes the growth and metastasis of colorectal cancer.
Zhang Y; Tian X; Ji H; Guan X; Xu W; Dong B; Zhao M; Wei M; Ye C; Sun Y; Yuan X; Yang C; Hao C
PLoS One; 2014; 9(6):e100413. PubMed ID: 24971456
[TBL] [Abstract][Full Text] [Related]
7. SATB1 promotes prostate cancer metastasis by the regulation of epithelial-mesenchymal transition.
Mao LJ; Yang CH; Fan L; Gao P; Yang DR; Xue BX; Zheng JN; Shan YX
Biomed Pharmacother; 2016 Apr; 79():1-8. PubMed ID: 27044805
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of SATB1 is associated with prostate cancer aggressiveness and disease progression.
Shukla S; Sharma H; Abbas A; MacLennan GT; Fu P; Danielpour D; Gupta S
PLoS One; 2013; 8(1):e53527. PubMed ID: 23308245
[TBL] [Abstract][Full Text] [Related]
9. Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathway.
Ma X; Yan W; Dai Z; Gao X; Ma Y; Xu Q; Jiang J; Zhang S
Drug Des Devel Ther; 2016; 10():1419-41. PubMed ID: 27143851
[TBL] [Abstract][Full Text] [Related]
10. SATB1 overexpression regulates the development and progression in bladder cancer through EMT.
Wan F; Cheng C; Wang Z; Xiao X; Zeng H; Xing S; Chen X; Wang J; Li S; Zhang Y; Xiang W; Zhu Z; Johnson C; Zhu Z
PLoS One; 2015; 10(2):e0117518. PubMed ID: 25706386
[TBL] [Abstract][Full Text] [Related]
11. SATB1 and SATB2 play opposing roles in c-Myc expression and progression of colorectal cancer.
Mansour MA; Hyodo T; Akter KA; Kokuryo T; Uehara K; Nagino M; Senga T
Oncotarget; 2016 Jan; 7(4):4993-5006. PubMed ID: 26701851
[TBL] [Abstract][Full Text] [Related]
12. SATB1 Promotes Pancreatic Cancer Growth and Invasion Depending on MYC Activation.
Chen Z; Li Z; Li W; Zong Y; Zhu Y; Miao Y; Xu Z
Dig Dis Sci; 2015 Nov; 60(11):3304-17. PubMed ID: 26108419
[TBL] [Abstract][Full Text] [Related]
13. SATB1 expression is correlated with β-catenin associated epithelial-mesenchymal transition in colorectal cancer.
Lv JH; Wang F; Shen MH; Wang X; Zhou XJ
Cancer Biol Ther; 2016; 17(3):254-61. PubMed ID: 26810818
[TBL] [Abstract][Full Text] [Related]
14. Activation of AKT signaling promotes epithelial-mesenchymal transition and tumor growth in colorectal cancer cells.
Suman S; Kurisetty V; Das TP; Vadodkar A; Ramos G; Lakshmanaswamy R; Damodaran C
Mol Carcinog; 2014 Feb; 53 Suppl 1():E151-60. PubMed ID: 24000138
[TBL] [Abstract][Full Text] [Related]
15. Loss of special AT-rich binding protein 1 expression is a marker of poor survival in lung cancer.
Selinger CI; Cooper WA; Al-Sohaily S; Mladenova DN; Pangon L; Kennedy CW; McCaughan BC; Stirzaker C; Kohonen-Corish MR
J Thorac Oncol; 2011 Jul; 6(7):1179-89. PubMed ID: 21597389
[TBL] [Abstract][Full Text] [Related]
16. Special AT-rich sequence-binding protein 1 promotes cell growth and metastasis in colorectal cancer.
Fang XF; Hou ZB; Dai XZ; Chen C; Ge J; Shen H; Li XF; Yu LK; Yuan Y
World J Gastroenterol; 2013 Apr; 19(15):2331-9. PubMed ID: 23613626
[TBL] [Abstract][Full Text] [Related]
17. Cellular prion protein accelerates colorectal cancer metastasis via the Fyn-SP1-SATB1 axis.
Wang Q; Qian J; Wang F; Ma Z
Oncol Rep; 2012 Dec; 28(6):2029-34. PubMed ID: 22972305
[TBL] [Abstract][Full Text] [Related]
18. Satb1 Overexpression Drives Tumor-Promoting Activities in Cancer-Associated Dendritic Cells.
Tesone AJ; Rutkowski MR; Brencicova E; Svoronos N; Perales-Puchalt A; Stephen TL; Allegrezza MJ; Payne KK; Nguyen JM; Wickramasinghe J; Tchou J; Borowsky ME; Rabinovich GA; Kossenkov AV; Conejo-Garcia JR
Cell Rep; 2016 Feb; 14(7):1774-1786. PubMed ID: 26876172
[TBL] [Abstract][Full Text] [Related]
19. Correlation of SATB1 overexpression with the progression of human rectal cancer.
Meng WJ; Yan H; Zhou B; Zhang W; Kong XH; Wang R; Zhan L; Li Y; Zhou ZG; Sun XF
Int J Colorectal Dis; 2012 Feb; 27(2):143-50. PubMed ID: 21870058
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of SATB1 by shRNA suppresses the proliferation of cutaneous malignant melanoma.
Zhang L; Cheng F; He R; Chen H; Liu Y; Sun J
Cancer Biother Radiopharm; 2014 Mar; 29(2):77-82. PubMed ID: 24392879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]